Even for diseases such as multiple sclerosis and type 1 diabetes in which attention has focused on a pathogenic role of IL-17, there is much evidence for involvement of IFN-γ+ cells (23, 24). The gene discussed is IL17A; the disease is type 1 diabetes mellitus.